ArticleHIV medicine2018

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens.

A Cozzi-Lepri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.